Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Imatinib Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Imatinib Drug market. Detailed analysis of key players, along with key growth strategies adopted by Imatinib Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Dr Reddy's Laboratories
Cipla Inc
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Actavis Generics
Novartis
Mylan Pharms Inc
Sanofi SA
Apotex Inc
Glenmark Pharmaceuticals Ltd
By Type:
Tablets
Capsules
By End-User:
Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Imatinib Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Imatinib Drug Market Size and Growth Rate of Tablets from 2016 to 2027
-
1.3.2 China Imatinib Drug Market Size and Growth Rate of Capsules from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Imatinib Drug Market Size and Growth Rate of Chronic Myelogenous Leukemia from 2016 to 2027
-
1.4.2 China Imatinib Drug Market Size and Growth Rate of Gastrointestinal Stromal Tumors from 2016 to 2027
-
1.4.3 China Imatinib Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Imatinib Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Imatinib Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Tablets
-
3.4.2 Market Size and Growth Rate of Capsules
4 Segmentation of Imatinib Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Imatinib Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Imatinib Drug in Chronic Myelogenous Leukemia
-
4.4.2 Market Size and Growth Rate of Imatinib Drug in Gastrointestinal Stromal Tumors
-
4.4.3 Market Size and Growth Rate of Imatinib Drug in Others
5 Market Analysis by Regions
-
5.1 China Imatinib Drug Production Analysis by Regions
-
5.2 China Imatinib Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Imatinib Drug Landscape Analysis
-
6.1 North China Imatinib Drug Landscape Analysis by Major Types
-
6.2 North China Imatinib Drug Landscape Analysis by Major End-Users
7 Central China Imatinib Drug Landscape Analysis
-
7.1 Central China Imatinib Drug Landscape Analysis by Major Types
-
7.2 Central China Imatinib Drug Landscape Analysis by Major End-Users
8 South China Imatinib Drug Landscape Analysis
-
8.1 South China Imatinib Drug Landscape Analysis by Major Types
-
8.2 South China Imatinib Drug Landscape Analysis by Major End-Users
9 East China Imatinib Drug Landscape Analysis
-
9.1 East China Imatinib Drug Landscape Analysis by Major Types
-
9.2 East China Imatinib Drug Landscape Analysis by Major End-Users
10 Northeast China Imatinib Drug Landscape Analysis
-
10.1 Northeast China Imatinib Drug Landscape Analysis by Major Types
-
10.2 Northeast China Imatinib Drug Landscape Analysis by Major End-Users
11 Southwest China Imatinib Drug Landscape Analysis
-
11.1 Southwest China Imatinib Drug Landscape Analysis by Major Types
-
11.2 Southwest China Imatinib Drug Landscape Analysis by Major End-Users
12 Northwest China Imatinib Drug Landscape Analysis
-
12.1 Northwest China Imatinib Drug Landscape Analysis by Major Types
-
12.2 Northwest China Imatinib Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Dr Reddy's Laboratories
-
13.1.1 Dr Reddy's Laboratories Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Cipla Inc
-
13.2.1 Cipla Inc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sun Pharmaceuticals
-
13.3.1 Sun Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Teva Pharmaceutical Industries Ltd
-
13.4.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Actavis Generics
-
13.5.1 Actavis Generics Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Novartis
-
13.6.1 Novartis Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Mylan Pharms Inc
-
13.7.1 Mylan Pharms Inc Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Sanofi SA
-
13.8.1 Sanofi SA Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Apotex Inc
-
13.9.1 Apotex Inc Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Glenmark Pharmaceuticals Ltd
-
13.10.1 Glenmark Pharmaceuticals Ltd Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Imatinib Drug Market Size and Growth Rate of Tablets from 2016 to 2027
-
Figure China Imatinib Drug Market Size and Growth Rate of Capsules from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Imatinib Drug Market Size and Growth Rate of Chronic Myelogenous Leukemia from 2016 to 2027
-
Figure China Imatinib Drug Market Size and Growth Rate of Gastrointestinal Stromal Tumors from 2016 to 2027
-
Figure China Imatinib Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Imatinib Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Imatinib Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Imatinib Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Imatinib Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Imatinib Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Tablets
-
Figure Market Size and Growth Rate of Capsules
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Imatinib Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Imatinib Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Chronic Myelogenous Leukemia
-
Figure Market Size and Growth Rate of Gastrointestinal Stromal Tumors
-
Figure Market Size and Growth Rate of Others
-
Table China Imatinib Drug Production by Regions
-
Table China Imatinib Drug Production Share by Regions
-
Figure China Imatinib Drug Production Share by Regions in 2016
-
Figure China Imatinib Drug Production Share by Regions in 2021
-
Figure China Imatinib Drug Production Share by Regions in 2027
-
Table China Imatinib Drug Consumption by Regions
-
Table China Imatinib Drug Consumption Share by Regions
-
Figure China Imatinib Drug Consumption Share by Regions in 2016
-
Figure China Imatinib Drug Consumption Share by Regions in 2021
-
Figure China Imatinib Drug Consumption Share by Regions in 2027
-
Table North China Imatinib Drug Consumption by Types from 2016 to 2027
-
Table North China Imatinib Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Imatinib Drug Consumption Share by Types in 2016
-
Figure North China Imatinib Drug Consumption Share by Types in 2021
-
Figure North China Imatinib Drug Consumption Share by Types in 2027
-
Table North China Imatinib Drug Consumption by End-Users from 2016 to 2027
-
Table North China Imatinib Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Imatinib Drug Consumption Share by End-Users in 2016
-
Figure North China Imatinib Drug Consumption Share by End-Users in 2021
-
Figure North China Imatinib Drug Consumption Share by End-Users in 2027
-
Table Central China Imatinib Drug Consumption by Types from 2016 to 2027
-
Table Central China Imatinib Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Imatinib Drug Consumption Share by Types in 2016
-
Figure Central China Imatinib Drug Consumption Share by Types in 2021
-
Figure Central China Imatinib Drug Consumption Share by Types in 2027
-
Table Central China Imatinib Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Imatinib Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Imatinib Drug Consumption Share by End-Users in 2016
-
Figure Central China Imatinib Drug Consumption Share by End-Users in 2021
-
Figure Central China Imatinib Drug Consumption Share by End-Users in 2027
-
Table South China Imatinib Drug Consumption by Types from 2016 to 2027
-
Table South China Imatinib Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Imatinib Drug Consumption Share by Types in 2016
-
Figure South China Imatinib Drug Consumption Share by Types in 2021
-
Figure South China Imatinib Drug Consumption Share by Types in 2027
-
Table South China Imatinib Drug Consumption by End-Users from 2016 to 2027
-
Table South China Imatinib Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Imatinib Drug Consumption Share by End-Users in 2016
-
Figure South China Imatinib Drug Consumption Share by End-Users in 2021
-
Figure South China Imatinib Drug Consumption Share by End-Users in 2027
-
Table East China Imatinib Drug Consumption by Types from 2016 to 2027
-
Table East China Imatinib Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Imatinib Drug Consumption Share by Types in 2016
-
Figure East China Imatinib Drug Consumption Share by Types in 2021
-
Figure East China Imatinib Drug Consumption Share by Types in 2027
-
Table East China Imatinib Drug Consumption by End-Users from 2016 to 2027
-
Table East China Imatinib Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Imatinib Drug Consumption Share by End-Users in 2016
-
Figure East China Imatinib Drug Consumption Share by End-Users in 2021
-
Figure East China Imatinib Drug Consumption Share by End-Users in 2027
-
Table Northeast China Imatinib Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Imatinib Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Imatinib Drug Consumption Share by Types in 2016
-
Figure Northeast China Imatinib Drug Consumption Share by Types in 2021
-
Figure Northeast China Imatinib Drug Consumption Share by Types in 2027
-
Table Northeast China Imatinib Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Imatinib Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Imatinib Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Imatinib Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Imatinib Drug Consumption Share by End-Users in 2027
-
Table Southwest China Imatinib Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Imatinib Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Imatinib Drug Consumption Share by Types in 2016
-
Figure Southwest China Imatinib Drug Consumption Share by Types in 2021
-
Figure Southwest China Imatinib Drug Consumption Share by Types in 2027
-
Table Southwest China Imatinib Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Imatinib Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Imatinib Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Imatinib Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Imatinib Drug Consumption Share by End-Users in 2027
-
Table Northwest China Imatinib Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Imatinib Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Imatinib Drug Consumption Share by Types in 2016
-
Figure Northwest China Imatinib Drug Consumption Share by Types in 2021
-
Figure Northwest China Imatinib Drug Consumption Share by Types in 2027
-
Table Northwest China Imatinib Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Imatinib Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Imatinib Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Imatinib Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Imatinib Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Dr Reddy's Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories
-
Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories
-
Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories
-
Table Product and Service Introduction of Dr Reddy's Laboratories
-
Table Company Profile and Development Status of Cipla Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla Inc
-
Figure Sales and Growth Rate Analysis of Cipla Inc
-
Figure Revenue and Market Share Analysis of Cipla Inc
-
Table Product and Service Introduction of Cipla Inc
-
Table Company Profile and Development Status of Sun Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Sun Pharmaceuticals
-
Table Product and Service Introduction of Sun Pharmaceuticals
-
Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd
-
Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd
-
Table Company Profile and Development Status of Actavis Generics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Generics
-
Figure Sales and Growth Rate Analysis of Actavis Generics
-
Figure Revenue and Market Share Analysis of Actavis Generics
-
Table Product and Service Introduction of Actavis Generics
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Mylan Pharms Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharms Inc
-
Figure Sales and Growth Rate Analysis of Mylan Pharms Inc
-
Figure Revenue and Market Share Analysis of Mylan Pharms Inc
-
Table Product and Service Introduction of Mylan Pharms Inc
-
Table Company Profile and Development Status of Sanofi SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA
-
Figure Sales and Growth Rate Analysis of Sanofi SA
-
Figure Revenue and Market Share Analysis of Sanofi SA
-
Table Product and Service Introduction of Sanofi SA
-
Table Company Profile and Development Status of Apotex Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex Inc
-
Figure Sales and Growth Rate Analysis of Apotex Inc
-
Figure Revenue and Market Share Analysis of Apotex Inc
-
Table Product and Service Introduction of Apotex Inc
-
Table Company Profile and Development Status of Glenmark Pharmaceuticals Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark Pharmaceuticals Ltd
-
Figure Sales and Growth Rate Analysis of Glenmark Pharmaceuticals Ltd
-
Figure Revenue and Market Share Analysis of Glenmark Pharmaceuticals Ltd
-
Table Product and Service Introduction of Glenmark Pharmaceuticals Ltd
-
